Raj Denhoy
Stock Analyst at Jefferies
(3.03)
# 1,394
Out of 5,058 analysts
55
Total ratings
68.09%
Success rate
24.45%
Average return
Main Sectors:
Stocks Rated by Raj Denhoy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Reiterates: Hold | $120 | $126.15 | -4.88% | 5 | Sep 26, 2024 | |
| EW Edwards Lifesciences | Maintains: Buy | $110 → $130 | $86.02 | +51.13% | 10 | Jul 30, 2021 | |
| HOLX Hologic | Maintains: Buy | $106 → $110 | $74.17 | +48.31% | 9 | Apr 5, 2021 | |
| PROF Profound Medical | Initiates: Buy | n/a | $6.02 | - | 1 | Sep 15, 2020 | |
| DXCM DexCom | Maintains: Buy | $29 → $31 | $59.73 | -47.68% | 8 | Aug 2, 2018 | |
| AXGN Axogen | Initiates: Buy | $35 | $25.26 | +38.56% | 1 | Nov 30, 2017 | |
| TFX Teleflex | Maintains: Buy | $270 → $295 | $105.70 | +179.09% | 9 | Nov 3, 2017 | |
| LIVN LivaNova | Maintains: Buy | $80 → $91 | $53.91 | +68.80% | 3 | Nov 3, 2017 | |
| LNTH Lantheus Holdings | Maintains: Buy | $22 → $27 | $52.79 | -48.85% | 2 | Nov 3, 2017 | |
| PODD Insulet | Maintains: Buy | $58 → $67 | $346.36 | -80.66% | 7 | Nov 3, 2017 |
Abbott Laboratories
Sep 26, 2024
Reiterates: Hold
Price Target: $120
Current: $126.15
Upside: -4.88%
Edwards Lifesciences
Jul 30, 2021
Maintains: Buy
Price Target: $110 → $130
Current: $86.02
Upside: +51.13%
Hologic
Apr 5, 2021
Maintains: Buy
Price Target: $106 → $110
Current: $74.17
Upside: +48.31%
Profound Medical
Sep 15, 2020
Initiates: Buy
Price Target: n/a
Current: $6.02
Upside: -
DexCom
Aug 2, 2018
Maintains: Buy
Price Target: $29 → $31
Current: $59.73
Upside: -47.68%
Axogen
Nov 30, 2017
Initiates: Buy
Price Target: $35
Current: $25.26
Upside: +38.56%
Teleflex
Nov 3, 2017
Maintains: Buy
Price Target: $270 → $295
Current: $105.70
Upside: +179.09%
LivaNova
Nov 3, 2017
Maintains: Buy
Price Target: $80 → $91
Current: $53.91
Upside: +68.80%
Lantheus Holdings
Nov 3, 2017
Maintains: Buy
Price Target: $22 → $27
Current: $52.79
Upside: -48.85%
Insulet
Nov 3, 2017
Maintains: Buy
Price Target: $58 → $67
Current: $346.36
Upside: -80.66%